Lodenafil carbonate structure
|
Common Name | Lodenafil carbonate | ||
---|---|---|---|---|
CAS Number | 398507-55-6 | Molecular Weight | 1035.20000 | |
Density | N/A | Boiling Point | 1109.0±75.0 °C(Predicted) | |
Molecular Formula | C47H62N12O11S2 | Melting Point | 229-231 °C | |
MSDS | N/A | Flash Point | N/A |
Use of Lodenafil carbonateLodenafil carbonate, a dimer that acts as a prodrug delivering Lodenafil in vivo, is an orally active phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED)[1][2]. |
Name | bis[2-[4-[4-ethoxy-3-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]sulfonylpiperazin-1-yl]ethyl] carbonate |
---|---|
Synonym | More Synonyms |
Description | Lodenafil carbonate, a dimer that acts as a prodrug delivering Lodenafil in vivo, is an orally active phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED)[1][2]. |
---|---|
Related Catalog | |
Target |
PDE5 |
References |
Boiling Point | 1109.0±75.0 °C(Predicted) |
---|---|
Melting Point | 229-231 °C |
Molecular Formula | C47H62N12O11S2 |
Molecular Weight | 1035.20000 |
Exact Mass | 1034.41000 |
PSA | 279.13000 |
LogP | 5.04220 |
Lodenafil Carbonate |